CAR-T
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
60
NCT04690595
BAFFR Targeting CAR-T Cells for the Treatment of Relapsed or Refractory B-cell ALL
Phase: Phase 1
Role: Lead Sponsor
Start: May 18, 2021
Completion: Nov 18, 2027
NCT05370430
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
Start: Jun 13, 2022
Completion: Jun 13, 2028
Loading map...